Landscapes / Targets
MEK
6 drugs act on MEK, in 22 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs6
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Kinase inhibitor |
Approved | 27 Nov 2026soonPhase 1 trial completes | |||
| How it works | Blocks a kinase | ||||
| Next date | 27 Nov 2026 · Phase 1 trial completes | ||||
| Also tested for | Plexiform Neurofibroma, Neurofibromatosis Type 1 (NF1) and 2 more | ||||
| Open drug page | |||||
Tyrosine kinase inhibitor |
Approved in China | 24 Dec 2026Phase 3 trial completes | |||
| How it works | Blocks a kinase | ||||
| Next date | 24 Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Neurofibromatosis 1, Plexiform Neurofibromas and 2 more | ||||
| Open drug page | |||||
Tyrosine kinase inhibitor |
Approved | 1 Aug 2027Phase 2 trial completes | |||
| How it works | Blocks a kinase | ||||
| Next date | 1 Aug 2027 · Phase 2 trial completes | ||||
| Also tested for | Ovarian Cancer, Low Grade Ovarian Serous Adenocarcinoma and 6 more | ||||
| Open drug page | |||||
MEK inhibitor |
AstraZeneca · Public AZN |
Approved | 30 Nov 2027Phase 1/2 trial completes | ||
| Next date | 30 Nov 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Neurofibromatosis 1, Neurofibromatosis Type 1 and 8 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Mar 2027Phase 1/2 trial completes | |||
| Next date | Mar 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Neovascular (Wet) Age-Related Macular Degeneration | ||||
| Open drug page | |||||
— |
Phase 1 | Nov 2028Phase 1 trial completes | |||
| Next date | Nov 2028 · Phase 1 trial completes | ||||
| Also tested for | Oncology, MEK Mutation and 7 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 6 of 6 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026